Is a complete CSE/RVV research report available?

Question

Accepted Answer

No complete published report is available for cse/RVV (CSE/RVV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap	10.9M
Net income (ttm)	-10.6M
EPS (ttm)	-CA$0.02
Shares out	435.7M
Volume	132,100
Beta	-1.85

Metric	Value
Country	Canada
Country code	CA
Employees	2
Enterprise value	CAD 11M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE Fwd	21.89
Isin	CA7615161030
Last refreshed	2026-09-09
Market cap	CAD 10.9M
Price	CAD 0.03
Price currency	CAD
Sector	Healthcare
Sic	2836
Symbol	cse/RVV
Website	https://revivethera.com

Metric	Value
Earnings Yield	-97.54%
FCF yield	-1.44%
P/B ratio	-2.71x

Metric	Value
Net Income	CAD -10.6M
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Profit Per Employee	CAD -5.3M
ROA	-16.45
Roa5y	-33.24
ROCE	33.66
ROE	-1,108.4
Roe5y	-179.5
ROIC	-79.37

Metric	Value
Cagr10y	-15.2%
Cagr1y	25.02%
Cagr3y	-14.5%
Cagr5y	-43.13%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth Years	0x

CSE/RVV (CSE/RVV)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/RVV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/RVV indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on CSE/RVV

Frequently asked questions

Metric	Value
Assets	CAD 281,775
Cash	CAD 12,665
Current Assets	CAD 149,326
Current Liabilities	CAD 4.2M
Debt	CAD 70,770
Debt FCF	CAD -0.45
Equity	CAD -4M
Liabilities	CAD 4.3M
Long Term Assets	CAD 132,449
Long Term Liabilities	CAD 151,744
Net Cash	CAD -58,105
Net Cash By Market Cap	CAD -0.53
Tangible Book Value	CAD -4M
Tangible Book Value Per Share	CAD -0.01
WACC	-5.88

Metric	Value
Current ratio	0.04
Net Working Capital	CAD -4M
Quick ratio	0.02
Working Capital	CAD -4M

Metric	Value
10Y total return	-80.77%
1Y total return	25%
200-day SMA	0.02
3Y total return	-37.5%
50-day SMA	0.03
50-day SMA vs 200-day SMA	50over200
5Y total return	-94.05%
All Time High	0.96
All Time High Change	-97.4%
All Time High Date	2014-09-03
All Time Low	0.01
All Time Low Change	400%
All Time Low Date	2024-06-27
ATR	0
Beta	-1.85
Beta1y	-6.44
Beta2y	-1.92
Ch YTD	150
High	0.03
High52	0.08
High52 Date	2026-03-17
High52ch	-68.75%
Low	0.03
Low52	0.01
Low52 Date	2025-12-03
Low52ch	400%
Ma50ch	-10.71%
Price vs 200-day SMA	0.81%
RSI	47.56
RSI Monthly	45.04
RSI Weekly	47.48
Sharpe ratio	1.53x
Sharpe Ratio3y	1.58x
Sharpe Ratio5y	1.12x
Sortino ratio	2.78
Sortino Ratio3y	3.15
Sortino Ratio5y	2.18
Total Return	-2.97%
Tr YTD	150
Tr3m	-28.57%

Metric	Value
Float	429,348,973%
Shares Insiders	1.45%
Shares Institutions	0%
Shares Out	435,676,173
Shares Qo Q	0%
Shares Yo Y	2.97%

Metric	Value
Adjusted FCF	CAD -665,329
Adjusted OCF	-665,329
Average Volume	256,096.5x
Bv Per Share	-0.01
Ch10y	-80.77
Ch1y	25
Ch3m	-28.57
Ch3y	-37.5
Ch5y	-94.05
Ch6m	25
Change	0%
Change From Open	0
Close	0.03
Days Gap	0
Depreciation Amortization	203
Dollar Volume	3,302.5
Earnings Date	2026-09-16
EBIT	CAD -1.3M
EBITDA	CAD -1.3M
EPS	CAD -0.02
F Score	2
FCF	CAD -156,711
FCF EV Yield	-1.43x
FCF Per Share	CAD -0
Financing CF	122,952
Fiscal Year End	June
Is Primary Listing	1
Last Earnings Date	2026-02-26
Last Report Date	2026-03-31
Ma150	0.03
Ma150ch	-13.79%
Ma20	0.03
Ma20ch	-8.42%
Net CF	-33,759
Next Earnings Date	2026-09-16
Open	0.03
Ppne	687
Price Date	2026-09-08
Relative Volume	0.52x
Share Based Comp	508,618
Tr6m	25%
Volume	132,100